Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

New State-of-the-Art Facility Will Create Nearly 500 Skilled Jobs and Accelerate the Delivery of Next-Generation Medicines

Investment Furthers BMS’ $40 Billion Commitment to American Innovation, Manufacturing and Economic Growth

Bristol Myers Squibb (NYSE:BMY) today announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion investment designed to accelerate the delivery of next-generation medicines to patients. The campus, at Generation Park in Houston, will create nearly 500 skilled jobs and is designed to grow in scale, capability and workforce for decades to come.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260810766100/en/ Rendering of Bristol Myers Squibb's planned $2.3 billion state-of-the-art manufacturing campus in Houston, Texas.